Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y J Bryson

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Infectious Diseases|September 1, 1986
Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferonT L Kuhls, J Sacher, E Pineda, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrencesM J Levin, F N Judson, L Eron, et al.
The Journal of Infectious Diseases|April 1, 1996
Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infantsK Nielsen, P Boyer, M Dillon, et al.
Journal of Medical Virology|January 1, 1993
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysisJ C Huff, J L Drucker, A Clemmer, et al.
Pediatric Research|July 1, 1993
In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected childrenM E Geffner, D Y Yeh, E M Landaw, et al.
The Journal of Infectious Diseases|August 1, 1995
Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assayK Nielsen, L S Wei, M S Sim, et al.
The American Journal of Medicine|August 29, 1988
Therapy of herpes zoster with oral acyclovirJ C Huff, B Bean, H H Balfour, et al.
American Journal of Obstetrics and Gynecology|May 1, 1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working GroupM J O'Sullivan, P J Boyer, G B Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1992
The management of pregnancies complicated by genital infections with herpes simplex virusC G Prober, L Corey, Z A Brown, et al.
The Journal of Infectious Diseases|August 19, 2000
Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapyO Equils, E Garratty, L S Wei, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Infectious Diseases|September 1, 1986
Suppression of recurrent genital herpes simplex virus infection with recombinant alpha 2 interferonT L Kuhls, J Sacher, E Pineda, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1989
Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrencesM J Levin, F N Judson, L Eron, et al.
The Journal of Infectious Diseases|April 1, 1996
Presence of human immunodeficiency virus (HIV) type 1 and HIV-1-specific antibodies in cervicovaginal secretions of infected mothers and in the gastric aspirates of their infantsK Nielsen, P Boyer, M Dillon, et al.
Journal of Medical Virology|January 1, 1993
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysisJ C Huff, J L Drucker, A Clemmer, et al.
Pediatric Research|July 1, 1993
In vitro insulin-like growth factor-I, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected childrenM E Geffner, D Y Yeh, E M Landaw, et al.
The Journal of Infectious Diseases|August 1, 1995
Correlation of clinical progression in human immunodeficiency virus-infected children with in vitro zidovudine resistance measured by a direct quantitative peripheral blood lymphocyte assayK Nielsen, L S Wei, M S Sim, et al.
The American Journal of Medicine|August 29, 1988
Therapy of herpes zoster with oral acyclovirJ C Huff, B Bean, H H Balfour, et al.
American Journal of Obstetrics and Gynecology|May 1, 1993
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working GroupM J O'Sullivan, P J Boyer, G B Scott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1992
The management of pregnancies complicated by genital infections with herpes simplex virusC G Prober, L Corey, Z A Brown, et al.
The Journal of Infectious Diseases|August 19, 2000
Recovery of replication-competent virus from CD4 T cell reservoirs and change in coreceptor use in human immunodeficiency virus type 1-infected children responding to highly active antiretroviral therapyO Equils, E Garratty, L S Wei, et al.
Pageof 7